SHREVEPORT, La., May 24, 2002 (PRIMEZONE) -- EquityOutlook.Com (IARD#118718) -- www.equityoutlook.com -- evaluates the following stocks: (Get FREE ratings at http://www.equityoutlook.com/index.htm)
IDEC Pharmaceuticals Corp (Nasdaq:IDPH) - Outperform Merck & Co (NYSE:MRK) - Underperform Advanced Micro Devices (NYSE:AMD) - Outperform Cendant Corp (NYSE:CD) - Outperform Duke Energy Corp (NYSE:DUK) - Outperform
WHAT THESE RATINGS MEAN:
These stocks are rated with a proprietary system of technical analysis. These ratings do not indicate a "long term" view of any company listed. These are ratings that indicate our opinion of a stock's PRICE movement versus the SP 500 over the short term. "Mainstream wallstreet" implores traders to "buy and hold." This strategy proves at times to be DISASTROUS. We believe that traders should find entry and exit positions over the short term to take profits or conserve capital.
Investors can find more ratings at: www.equityoutlook.com/index.htm
Investors that want a TRULY unbiased stock rating service should visit: http://www.equityoutlook.com/reports.htm
Disclaimer: EquityOutlook.Com (a StockLogix.Com, LLC company) is a registered investment adviser in the State of Louisiana (IARD#118718). No information accessed through the EquityOutlook.Com, or any link contained on the EquityOutlook.Com Web site, constitutes a recommendation by EquityOutlook.Com to buy, sell or hold any security, financial product, or instrument discussed therein. Information accessed through linked sites neither is, nor should be construed as, an offer, or a solicitation of an offer, to buy or sell securities by EquityOutlook.Com. EquityOutlook.Com does not hold positions in securities being discussed in this news release and/or mentioned on the EquityOutlook.Com Web site. Investors shall be fully responsible for any investment decisions they make, and such decisions will be based solely on their evaluation of their financial circumstances, investment objectives, risk tolerance and liquidity needs. Investors are encouraged to consult with their registered broker and/or investment adviser before making any investment decision.